Injectable Lidocaine Versus Lidocaine/Tetracaine Patch for the Incision and Drainage of Skin Abscesses
Injectable Lidocaine Provides Similar Analgesia Compared to Transdermal Lidocaine/Tetracaine Patch for the Incision and Drainage of Skin Abscesses: A Randomized Controlled Trial
1 other identifier
interventional
20
0 countries
N/A
Brief Summary
Local anesthesia used for incision and drainage of abscesses is known to be painful. We studied the analgesia provided by a lidocaine/tetracaine patch compared to injectable lidocaine during incision and drainage (I\&D) of skin abscesses. Local injection of lidocaine provided similar analgesia compared to the lidocaine/tetracaine patch during I\&D of skin abscesses in the Emergency Department. Pain at presentation and following the procedure was similar in both groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for early_phase_1
Started Jan 2008
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2010
CompletedFirst Submitted
Initial submission to the registry
November 18, 2013
CompletedFirst Posted
Study publicly available on registry
February 20, 2014
CompletedFebruary 20, 2014
February 1, 2014
2 years
November 18, 2013
February 18, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in VAS pain score over time
VAS measured at each of the 3 time points noted above.
Immediately prior to starting I&D (Time 0); 2-5 minutes after start of I&D (Time 1); within 1 minute of completion of I&D (Time 2)
Study Arms (2)
Lidocaine Injection
ACTIVE COMPARATORIncision and drainage performed after patient received placebo patch with injection of 1% lidocaine into the site of the abscess.
Lidocaine/tetracaine patch
EXPERIMENTALIncision and drainage performed after patient received active lidocaine/tetracaine patch and injection of 10cc of saline into site of abscess
Interventions
Eligibility Criteria
You may qualify if:
- Age\>18 years
- Skin abscess in need of incision and drainage (judged by treating physician)
You may not qualify if:
- Allergy to lidocaine or tetracaine
- Non-intact skin
- Unable/unwilling to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christina L Bourne, MD
Medical University of South Carolina
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Assistant Professor
Study Record Dates
First Submitted
November 18, 2013
First Posted
February 20, 2014
Study Start
January 1, 2008
Primary Completion
January 1, 2010
Study Completion
January 1, 2010
Last Updated
February 20, 2014
Record last verified: 2014-02